How often do anaphylactic reactions occur after subcutaneous immunotherapy (SCIT) in allergic asthma?
Evidence suggests the risk of anaphylactic reactions after SCIT in allergic asthma is low but not negligible. Careful patient monitoring and readiness to manage anaphylaxis are essential in clinical settings administering SCIT.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-02
- DOI
- https://doi.org/10.5281/zenodo.23891752
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00